Emil D. Kakkis
2014
In 2014, Emil D. Kakkis earned a total compensation of $699K as President and Chief Executive Officer at Ultragenyx Pharmaceutical, a 2% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $175,000 |
|---|---|
| Salary | $496,867 |
| Other | $27,163 |
| Total | $699,030 |
Kakkis received $496.9K in salary, accounting for 71% of the total pay in 2014.
Kakkis also received $175K in non-equity incentive plan and $27.2K in other compensation.
Rankings
In 2014, Emil D. Kakkis' compensation ranked 9,056th out of 13,032 executives tracked by ExecPay. In other words, Kakkis earned more than 30.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,056 out of 13,032 | 31st |
Division Manufacturing | 3,392 out of 4,966 | 32nd |
Major group Chemicals And Allied Products | 1,150 out of 1,686 | 32nd |
Industry group Drugs | 911 out of 1,365 | 33rd |
Industry Pharmaceutical Preparations | 698 out of 1,043 | 33rd |
Source: SEC filing on April 28, 2017.
Kakkis' colleagues
We found three more compensation records of executives who worked with Emil D. Kakkis at Ultragenyx Pharmaceutical in 2014.